COMMUNIQUÉS West-GlobeNewswire

UPM launches a new, economical solution for the thin print market
22/06/2017
(UPM, Helsinki, 22 June 2017 at 14:00 EET) - The Biofore company UPM has launched a new solution for the thin print market. The revolutionary paper, UPM EcoLite, has been specially designed to meet the needs of [...]
UPM propose une nouvelle solution économique pour le marché des papiers minces
22/06/2017
(UPM, Helsinki, 22 juin 2017, 14h00 EET) - Le fabricant de papier UPM lance une nouvelle solution pour le marché des papiers minces. Ce papier révolutionnaire, UPM EcoLite, a été spécialement conçu pour répondre aux [...]
Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA
22/06/2017
Reference is made to the stock exchange notice of 14 June 2017 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units. [...]
Phase 2a trial results support development of dasiglucagon in the iLet pump system for type 1 diabetes
22/06/2017
Dasiglucagon* is a potential first-in-class glucagon analog for prevention and treatment of low blood sugar in type 1 diabetes using an automated pump system Dasiglucagon was dosed using the iLet (TM) platform, a state- [...]
Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development
22/06/2017
Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development Herantis Pharma Plc Company release 22 June 2017 at 9:00 am Herantis Pharma Plc's ("Herantis [...]
Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack
22/06/2017
Phase III CANTOS study met the primary endpoint, a composite of heart attack, stroke and cardiovascular death, showing that ACZ885 (canakinumab) in combination with standard of care therapy reduces cardiovascular risk [...]
Santhera's Raxone® Receives First Positive EAMS Scientific Opinion from UK's MHRA in Duchenne Muscular Dystrophy
22/06/2017
Liestal, Switzerland, June 22, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted Raxone (idebenone) a positive scientific opinion [...]
HalioDx receives CLIA Compliance for Immunoscore® Colon
21/06/2017
HalioDx receives CLIA Compliance for Immunoscore® Colon HalioDx received CMS [1] CLIA Compliance for its laboratory based in Marseille Immunoscore® Colon, is now available to US patients in selected states with a [...]
Mithra Pharmaceuticals: MITHRA SUCCESSFULLY RAISES €26.1 MILLION
21/06/2017
NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS RELEASE REGULATED INFORMATION - INSIDE [...]
Amer Sports half-year 2017 financial report published on July 27
21/06/2017
Amer Sports Corporation STOCK EXCHANGE RELEASE June 21, 2017 at 2:15 p.m. Amer Sports half-year 2017 financial report published on July 27 Amer Sports Corporation will publish its half-year financial report 2017 on [...]
Hemcheck Sweden AB: Presents results from user tests at Karlstad Central Hospital
21/06/2017
Hemcheck Sweden AB (publ) presents results from user tests at Karlstad Central Hospital hemCheck, a medical technology company addressing the issue of hemolysis, announces results from user tests at Karlstad Central [...]
A study of elite athletes shows that ColdZyme provides protection as evidenced by fewer sick days and lost training days, as well as improved quality of life
21/06/2017
News Enzymatica Study Elite Athletes Eng 170621 This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they [...]
Mithra Pharmaceuticals: MITHRA LAUNCHES A CAPITAL INCREASE BY MEANS OF A PRIVATE PLACEMENT VIA AN ACCELERATED BOOKBUILD OFFERING
21/06/2017
NOT FOR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL PRESS RELEASE REGULATED INFORMATION - INSIDE [...]
Novartis achieves important regulatory milestone for AMG 334 (erenumab) in migraine prevention with EMA filing acceptance
21/06/2017
AMG 334 (erenumab) is the first anti-CGRP monoclonal antibody developed for migraine prevention to receive EMA regulatory filing acceptance Filing is supported by a comprehensive clinical program of over 2,600 migraine [...]
MITHRA COMPLETES RECRUITMENT FOR ADDITIONAL ESTELLE® SAFETY STUDY
21/06/2017
PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR ADDITIONAL estelle® SAFETY studY Safety study is part of the development of Estelle®, Mithra's combined oral contraceptive candidate Aim of the study is to analyze a broad [...]
Novo Nordisk receives positive 17-2 vote from FDA Advisory Committee that Victoza® provides substantial evidence of cardiovascular risk reduction in patients with type 2 diabetes
20/06/2017
Bagsværd, Denmark, 20 June 2017 - Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) has completed its meeting regarding the [...]
Galapagos increases share capital through warrant exercises
20/06/2017
Mechelen, Belgium; 20 June 2017, 22.00 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 52,030 new ordinary [...]
Oriola Corporation starts repurchase of its own class B shares in connection with the company's incentive schemes
20/06/2017
Oriola Corporation Stock Exchange Release 20 June 2017 18.00 Oriola Corporation starts repurchase of its own class B shares in connection with the company's incentive schemes The Board of Directors of Oriola Corporation [...]
New Data Reveal Medtronic CRT Devices Improve Therapy Delivery and Reduce Healthcare Costs
20/06/2017
Data Presented at EUROPACE 2017 Reinforce Cost and Outcome Benefits of Exclusive EffectivCRT(TM) and AdaptivCRT(TM) Algorithms, Along with Improved Device Longevity DUBLIN and VIENNA - June 20, 2017 - Medtronic plc ( [...]

Pages